Geneva – The flu vaccine for the 2010/2011 winter season in the northern hemisphere is expected to contain three strains of influenza, including A(H1N1), commonly known as swine flu, the World Health Organization said Thursday. The other two strains …
See the rest here:
WHO: Seasonal flu vaccine expected to include swine flu strain (EARTHtimes.org)
Novavax, Inc. (Nasdaq: NVAX) announced new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax’s trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains…
Read more here:
NOVAVAX Reports Additional Positive Data From Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study In Healthy … (Medical News Today)
Novavax, Inc. announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax’s trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains.
See the rest here:
Novavax announces new data from trivalent seasonal influenza VLP vaccine study (News-Medical-Net)
The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains. The study enrolled 241 subjects, including 221 who were …
See the original post here:
NOVAVAX Reports Additional Positive Data from Its Trivalent …
Also less rituximab-treated patients reached levels of antibodies needed for protection against influenza for the A/ H3N2 and seasonal A/H1N1 when compared with MTX-treated patients, and for the seasonal A/H1N1 when compared with healthy …
Follow this link:
Science Centric | News | Efficacy of flu vaccine drastically …
However, in the late rituximab subgroup, a rise in GMT for the A/ H3N2 and A/H1N1 strains was demonstrated, in the absence of a repopulation of CD19+ cells at the time of vaccination. Seroconversion and seroprotection occurred less often …
Read the original here:
A TIME'S MEMORY: Humoral responses after influenza vaccination are …
Also less rituximab-treated patients reached levels of antibodies needed for protection against influenza for the A/ H3N2 and seasonal A/H1N1 when compared with MTX-treated patients, and for the seasonal A/H1N1 when compared with healthy …
See the rest here:
Efficacy of flu vaccine drastically reduced for RA patients …
Of the five seasonal influenza A ( H3N2 ) viruses characterized, one was related to A/Brisbane/10/07, which is the influenza A/ H3N2 component recommended for the 2009-10 influenza vaccine and four viruses were antigenically related to …
More here:
Canada: FluWatch Week 50
The test is a targeted sequencing assay intended for the in vitro qualitative detection of the 2009 H1N1 influenza A virus. The firm said the assay is aided by an algorithm that relies on seasonal A/H1N1 and seasonal A/ H3N2 influenza …
Originally posted here:
FDA Authorizes TessArae's RM-Flu Chip for Emergency H1N1 Testing …
SANTA CLARA, Calif. & POTOMAC FALLS, Va.—-TessArae, LLC, a privately held company, and Affymetrix Inc., today announced that the Food and Drug Administration has granted Emergency Use Authorization to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus for the duration of the declaration of emergency unless …
See the article here:
FDA Grants Emergency Use Authorization for TessArae® 2009 H1N1 Influenza A Virus Assay Based on the Affymetrix® … (Business Wire via Yahoo!…